A study presented today at the European Congress on Osteoporosis and Osteoarthritis currently taking place in Valencia, Spain has found that the initial quality of life loss following an osteoporotic fracture is substantial, especially with regard to hip and vertebral fractures. The study found differences in quality of life loss between countries after correcting for other explanatory variables. Read more
The use of high-resolution peripheral quantitative computed tomography (HR-pQCT) to assess bone microarchitecture in clinical studies has continued to grow rapidly. Thus, there is an urgent need for guidance and consensus on the methods for and reporting of HR-pQCT imaging so that different studies can be compared to each other. Read more
El uso de la tomografía computarizada cuantitativa periférica de alta resolución (HR-pQCT) para evaluar la microarquitectura ósea en los estudios clínicos continúa creciendo rápidamente. Por consiguiente, existe la urgente necesidad de orientación y consenso sobre los métodos para la obtención de imágenes de la HR-pQCT y la presentación de informes a fin de poder comparar los distintos estudios... Read more
On March 3 2020, project coordinator Professor Tobias Winkler, welcomed 37 participants at the start of the 2nd Annual Meeting of the HIPGEN project, held at the Steigenberger Hotel Am Kanzleramt, Berlin. Due to Covid-19 restrictions, 7 participants from Italy and Israel were participating via Video conference from their countries. Read more
A new International Osteoporosis Foundation (IOF) position paper reviews experimental and clinical evidence showing that hip bone strength estimated by bone mineral density (BMD) and/or finite element analysis (FEA) reflects the actual strength of the proximal femur. Read more
In 2018 the International Osteoporosis Foundation (IOF) and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) published the updated European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Read more
The RegMed Forum which took place in Berlin on Oct 22, 2019, was attended by experts from the Brandburger region of Germany and this year focused on exchange between patients, physicians and scientists on the latest developments, risks, and opportunities afforded by new cell and gene therapies. Read more
In seniors, hip fractures and resulting immobility result in high morbidity, and mortality of up to 30% in the first year. As yet, there is no therapy available to address the problem of impaired regeneration and mobility, and the consequences (including high mortality) after hip fracture surgery. Hipgen is a multicenter phase III trial which aims to bring allogenic placental cell therapy with... Read more
Advances in the treatment of children and adolescents with cancer have led to substantial improvements in survival, with a 5-year survival rate of childhood cancer close to 80%. Read more
The Meeting, organized by the HIPGEN project’s coordinator Dr Tobias Winkler (Charité - Universitätsmedizin Berlin) in collaboration with host organization ALTA, brought together more than 30 participants representing a network of ten organizations located in eight countries. It was an important opportunity for all the key stakeholders to update each other on progress and discuss current... Read more


Subscribe to Research